Uncover key drivers, emerging technologies, and competitive movements shaping the crohn’s disease treatment market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Crohn’s Disease Treatment Market covering 2026–2035?
The crohn’s disease treatment market has experienced significant growth in recent years. Its value is anticipated to rise from $13.1 billion in 2025 to $13.99 billion in 2026, expanding at a compound annual growth rate (CAGR) of 6.8%. This historical expansion can be attributed to factors like the increasing prevalence of crohn’s disease, heightened awareness of inflammatory bowel diseases, the expansion of hospital pharmacy networks, the availability of conventional anti-inflammatory drugs, and improved diagnostic capabilities.
The crohn’s disease treatment market is projected for substantial expansion over the next few years. It is anticipated to grow to $18.86 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period can be attributed to the expanding pipeline of biologics and small molecules, increasing demand for personalized treatment, the rise in online pharmacy penetration, growing healthcare expenditure in emerging markets, and an emphasis on long-term disease management. Key trends expected in the forecast period include the increasing adoption of biologic therapies, a shift towards early and aggressive treatment approaches, a heightened focus on steroid-sparing regimens, the development of oral small-molecule therapies, and the broadening of online and specialty pharmacy channels.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Crohn’s Disease Treatment Market?
The anticipated expansion of the Crohn’s disease treatment market is linked to the growing occurrence of inflammatory bowel disorders. These disorders are chronic conditions characterized by inflammation within the gastrointestinal tract, which can lead to inflammation and damage anywhere along the digestive system, from the mouth to the anus. Effective management of Crohn’s disease involves reducing intestinal inflammation, averting symptom exacerbations, and sustaining periods of remission. For example, data from September 2023, sourced from the US-based National Center for Biotechnology Information, indicated a parallel rise in the prevalence of Crohn’s disease and ulcerative colitis. Inflammatory bowel disease was projected to affect 825 cases per 100,000 people in 2023, specifically 410 for Crohn’s disease and 414 for ulcerative colitis and IBD-u. Consequently, the increasing occurrence of these disorders is significantly driving the growth of the Crohn’s disease treatment market.
What Leading Segments Are Studied In The Crohn’s Disease Treatment Market?
The crohn’s disease treatment market covered in this report is segmented –
1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications
Subsegments:
1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics
2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates
3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids
4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine
5) By Other Drug Types: Biologics, Small Molecules, Other Treatments
Which Market Trends Are Opening Growth Opportunities In The Crohn’s Disease Treatment Market?
Leading companies operating within the crohn’s disease treatment market are engaged in innovating and securing approval for new drugs, such as biosimilar ustekinumab, to offer more effective and accessible treatment options for patients, ultimately enhancing patient outcomes and overall quality of life. Biosimilar ustekinumab is defined as a biologic drug that is highly similar to the original ustekinumab, a monoclonal antibody used for treating autoimmune conditions. As an example, in July 2024, Sandoz International GmbH, a Switzerland-based pharmaceutical company, launched Pyzchiva (ustekinumab) across Europe, establishing it as the first ustekinumab biosimilar available in all strengths, including a 130 mg vial specifically for Crohn’s disease. This product is indicated for adults and children over six years old suffering from plaque psoriasis, psoriatic arthritis, and Crohn’s disease, thereby strengthening Sandoz’s immunology portfolio while aiming to improve access to affordable treatments for chronic inflammatory disease.
Which Major Industry Participants Are Leading The Crohn’s Disease Treatment Market Growth?
Major companies operating in the crohn’s disease treatment market are AbbVie Inc., Janssen Pharmaceuticals, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Galapagos NV, Teva Pharmaceutical Industries Ltd., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim GmbH, Arena Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Which Region Is Expected To Experience The Fastest Growth In The Crohn’s Disease Treatment Market?
North America was the largest region in the global Crohn’s disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn’s disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Crohn’s Disease Treatment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10852&type=smp
Browse Through More Reports Similar to the Global Crohn’s Disease Treatment Market 2026, By The Business Research Company
Crohns Disease Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Crohns Disease Cd Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
Inflammatory Bowel Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model